The rationale behind autologous autoimmune hematopoietic stem cell transplant conditioning regimens: concerns over the use of total-body irradiation in systemic sclerosis

Bone Marrow Transplantation
R K BurtJ A Snowden

Abstract

Hematopoietic stem cell transplantation (HSCT) is becoming an increasingly recognized indication for treatment of autoimmune diseases and severe immune-mediated disorders. However, multicenter registry data have demonstrated higher than anticipated early toxicity, approximately 10% for autoimmune diseases in general, and 20-27% for diffuse systemic sclerosis (scleroderma). If uncorrected, this high treatment-related mortality will hinder development of stem cell therapy for immune-mediated diseases. In order to develop safer regimens, we address some pitfalls and concepts involved in design and selection of conditioning regimens for autoimmune diseases in general, and because it is associated with the highest regimen-related toxicity, scleroderma in specific.

References

Jun 26, 1991·JAMA : the Journal of the American Medical Association·J VargaS A Jimenez
Oct 1, 1990·The British Journal of Radiology·S G Cooper, J W Denham
Jun 1, 1989·The British Journal of Dermatology·G B ColverJ A Hunter
Oct 1, 1989·International Journal of Radiation Oncology, Biology, Physics·R FleckF A Holmes
Jul 1, 1986·Annals of Internal Medicine·E Ben-ChetritM Eliakim
Jan 21, 1985·The American Journal of Medicine·M B Urowitz, W D Rider
Jan 1, 1971·International Journal of Radiation Biology and Related Studies in Physics, Chemistry, and Medicine·A KeyeuxJ Van de Merckt
Jul 1, 1966·The British Journal of Radiology·S Vatistas, S Hornsey
Nov 1, 1994·International Journal of Cancer. Journal International Du Cancer·H A WeissR Doll
Apr 1, 1996·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·S DelanianM Housset
Jul 1, 1996·American Journal of Industrial Medicine·F TomeiM V Rosati
Oct 18, 2000·Advances in Cancer Research·P Pourquier, Y Pommier
Dec 2, 2000·Nature·B B Zhou, S J Elledge
Feb 24, 2001·Annals of the New York Academy of Sciences·S MiyamotoD A Boothman
May 18, 2001·Nature·J H Hoeijmakers
Jun 19, 2001·Annals of the Rheumatic Diseases·A TyndallA Gratwohl
Jul 24, 2001·Arthritis and Rheumatism·Z UhrinM C Genovese
Apr 16, 2002·Arthritis and Rheumatism·Mark C GenoveseSamuel Strober
Aug 6, 2002·Nature Medicine·Michelle L MonjeTheo D Palmer
Nov 20, 2002·British Journal of Haematology·Dominique FargeUNKNOWN Intensification et Autogreffe dans les Maladies Auto Immunes Resistantes (ISAMAIR) Study Group
Mar 13, 2003·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·H Ullén, E Björkholm
Jul 5, 2003·Rheumatic Diseases Clinics of North America·Christopher P Denton, Carol M Black

❮ Previous
Next ❯

Citations

Nov 19, 2004·Springer Seminars in Immunopathology·Richard K BurtShimon Slavin
Nov 18, 2008·Zeitschrift für Rheumatologie·I KötterL Kanz
Oct 18, 2011·Bone Marrow Transplantation·J A SnowdenUNKNOWN Paediatric Diseases Working Party (PDWP)
Dec 2, 2006·Nature Clinical Practice. Oncology·Pawel MuranskiNicholas P Restifo
Nov 19, 2010·Expert Review of Hematology·Claudio AnnaloroGiorgio Lambertenghi Deliliers
Nov 10, 2005·Annals of Medicine·Esa Jantunen, Riitta Luosujärvi
Sep 20, 2005·Trends in Immunology·Christopher P Denton, Carol M Black
Mar 17, 2009·Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E Biológicas·L V M OmmatiJ S R Oliveira
Feb 4, 2014·The Journal of Rheumatology·Gustavo Martelli PalominoEduardo A Donadi
Mar 7, 2021·Pharmaceuticals·Barbara RuaroCosimo Bruni

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.